Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith M Kerr

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
JCO Precision Oncology|February 12, 2025
Prevalence and Clinical Association of CD276 (B7-H3) Expression in Pleural Mesothelioma: Results From the European Thoracic Platform Mesoscape ProjectMartina Haberecker, Jan H Rüschoff, Charitini Andriakopoulou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 21, 2012
Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver studyErik Thunnissen, Mary Beth Beasley, Alain C Borczuk, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 22, 2018
Computer-Based Intensity Measurement Assists Pathologists in Scoring Phosphatase and Tensin Homolog Immunohistochemistry - Clinical Associations in NSCLC Patients of the European Thoracic Oncology Platform Lungscape CohortUndine Rulle, Zoi Tsourti, Ruben Casanova, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 12, 2022
Defining Morphologic Features of Invasion in Pulmonary Nonmucinous Adenocarcinoma With Lepidic Growth: A Proposal by the International Association for the Study of Lung Cancer Pathology CommitteeErik Thunnissen, Mary Beth Beasley, Alain Borczuk, et al.
The Lancet Regional Health. Europe|November 22, 2021
Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysisJohn K Field, Daniel Vulkan, Michael P A Davies, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape ProjectKeith M Kerr, Erik Thunnissen, Urania Dafni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 21, 2018
Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung CancerYasushi Yatabe, Sanja Dacic, Alain C Borczuk, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 4, 2021
The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLCMari Mino-Kenudson, Nolwenn Le Stang, Jillian B Daigneault, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 25, 2019
PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology CommitteeSylvie Lantuejoul, Ming Sound-Tsao, Wendy A Cooper, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2020
The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology CommitteeLynette M Sholl, Fred R Hirsch, David Hwang, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
JCO Precision Oncology|February 12, 2025
Prevalence and Clinical Association of CD276 (B7-H3) Expression in Pleural Mesothelioma: Results From the European Thoracic Platform Mesoscape ProjectMartina Haberecker, Jan H Rüschoff, Charitini Andriakopoulou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 21, 2012
Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver studyErik Thunnissen, Mary Beth Beasley, Alain C Borczuk, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 22, 2018
Computer-Based Intensity Measurement Assists Pathologists in Scoring Phosphatase and Tensin Homolog Immunohistochemistry - Clinical Associations in NSCLC Patients of the European Thoracic Oncology Platform Lungscape CohortUndine Rulle, Zoi Tsourti, Ruben Casanova, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 12, 2022
Defining Morphologic Features of Invasion in Pulmonary Nonmucinous Adenocarcinoma With Lepidic Growth: A Proposal by the International Association for the Study of Lung Cancer Pathology CommitteeErik Thunnissen, Mary Beth Beasley, Alain Borczuk, et al.
The Lancet Regional Health. Europe|November 22, 2021
Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysisJohn K Field, Daniel Vulkan, Michael P A Davies, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape ProjectKeith M Kerr, Erik Thunnissen, Urania Dafni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 21, 2018
Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung CancerYasushi Yatabe, Sanja Dacic, Alain C Borczuk, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 4, 2021
The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLCMari Mino-Kenudson, Nolwenn Le Stang, Jillian B Daigneault, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 25, 2019
PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology CommitteeSylvie Lantuejoul, Ming Sound-Tsao, Wendy A Cooper, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2020
The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology CommitteeLynette M Sholl, Fred R Hirsch, David Hwang, et al.
Pageof 12